Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.26 (
invertase
)
4,927
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two forms of secreted
invertase
have been purified from Aspergillus nidulans by ion-exchange and gel-filtration chromatography. S-
invertase
gave a single, broad, glycoprotein band on PAGE and SDS-PAGE corresponding in size to 185 and
78 kDa
, respectively, compared with 94 and 110 kDa for F-
invertase
. The carbohydrate of S-
invertase
contained mainly mannose (14%) and less galactose (5%) whereas the F-form yielded mainly galactose (29%) and less mannose (12%). Three sharp bands of enzymically active glycoprotein for both the S-form (pI 4.9-5.2) and the F-form (pI 3-4.2) were observed after isoelectric focusing. Deglycosylation with Endo H simplified this pattern to one enzymically active protein band (pI 5.2). The aglycoenzymes gave narrow bands on PAGE and SDS-PAGE corresponding to 115 kDa and 60 kDa respectively for both S- and F-forms. The specific activity of S-
invertase
was three-fold higher than that of F-
invertase
both before and after deglycosylation. The Km values of the two forms of
invertase
were very similar. Significant homology existed between the N-terminal amino-acid sequences of S-
invertase
(and of internal peptides derived from it) and sequences of
invertase
from other species. It is suggested that the higher carbohydrate content in F-
invertase
results in the native enzyme existing as a monomer and having a greater negative charge and lower specific enzyme activity compared with the dimeric S-enzyme.
...
PMID:Purification and partial characterization of the high and low molecular weight form (S- and F-form) of invertase secreted by Aspergillus nidulans. 881 28